Leadership Team
Michael Andreini
President and Chief Executive Officer
Stephanie Oestreich, Ph.D., MPA
Managing Director
Scientific Advisory Board
Randi Isaacs, M.D.
Executive Director and Clinical Site Head of Translational Clinical Oncology, Novartis Institutes for Biomedical Research
David R. Parkinson, M.D.
Chairman of the Clinical Advisory Board, Zyngenia, Inc.
Board of Directors
Thomas Conheeney
Retired President, SAC Capital
Dana LaForge
Partner, Brera Capital Partners, LLC
Hugh Martin
President & CEO, Lacuna Technologies Inc.
